You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

co-infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

Active, not recruiting
  • Chronic Hepatitis B and Hepatitis D Co-infection
  • HH-003 20mg/kg
  • HH-003 3mg/kg
  • Changchun, Jilin, China
    First Hospital of Jilin University
Dec 30, 2022

Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)

Not yet recruiting
  • Liver Cirrhosis
  • Bunkyo-Ku, Tokyo, Japan
    Tokyo Metropolitan Komagome Hospital
Nov 29, 2023

Hepatitis D Trial in Taipei (Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide)

Not yet recruiting
  • Hepatitis D
  • Ursodeoxycholic acid
  • +2 more
  • Taipei, Taiwan
  • +1 more
Jul 19, 2022

SARS CoV 2 Infection Trial in Astana (vibroacoustic therapy)

Completed
  • SARS CoV 2 Infection
  • vibroacoustic therapy
  • Astana, Kazakhstan
    NATIONAL CENTER Scientific Center of Traumatology and Orthopedic
Jan 11, 2022

Liver Cirrhosis Trial in Bunkyo-Ku (OP-724)

Active, not recruiting
  • Liver Cirrhosis
  • Bunkyo-Ku, Tokyo, Japan
    Tokyo Metropolitan Komagome Hospital
Jul 7, 2022

Surgical Site Infection After Episiotomy Repair Related to

Completed
  • Surgical Site Infection
  • Cairo, Egypt
    Ain Shams Maternity hospital
Nov 24, 2023

COPD Co-infection With Tuberculosis on Th17 Cell Differentiation

Completed
  • Tuberculosis Infection
  • Chronic Obstructive Pulmonary Disease
  • No intervention
  • Beijing, Beijing, China
    Peking University Third Hospital
Jul 14, 2021

HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)

Recruiting
  • HPV-Related Cervical Carcinoma
  • +3 more
  • CO2
  • Wenzhou, Zhejiang, China
    first affiliated hospital of Wenzhou medical university
Sep 23, 2023

Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

Available
  • Viral Hepatitis B
  • +6 more
  • REP 2139-Mg
  • +2 more
  • Vienna, Austria
  • +12 more
Feb 1, 2023

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia Trial in Nankoku

Recruiting
  • Complicated Urinary Tract Infection
  • +4 more
  • co-administration of cefepime and nacubactam
  • +2 more
  • Nankoku, Kochi, Japan
    Meiji Research Site
Jun 6, 2023

Bulevirtide in Patients With Chronic HBV/HDV Co-infection

Recruiting
  • Hepatitis D, Chronic
  • Hepatitis B, Chronic
    • Lyon, France
      ZOULIM
    Aug 5, 2021

    COVID-19 Trial in Shanghai (Azvudine, Placebo)

    Recruiting
    • COVID-19
    • Shanghai, Shanghai, China
      Huashan Hospital
    Jan 28, 2023

    Towards a Functional Cure for HBV - The COMMIT Cohort Study

    Active, not recruiting
    • Hiv
    • HBV Coinfection
      • Chennai, India
      • +2 more
      May 30, 2022

      Unified Standards Based on Gram Staining

      Not yet recruiting
      • Vaginal Infection
        • (no location specified)
        Aug 10, 2023

        Diagnosis of Tuberculosis Infection in HIV Co-infected Children

        Completed
        • Latent Tuberculosis Infection
        • +2 more
          • Tygerberg, Western Cape, South Africa
            Despond TuTu TB Centre, Stellenbosch University
          Jan 3, 2022

          Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection Trial in Hanzhou

          Active, not recruiting
          • Human Papilloma Virus Infection Type 16
          • +2 more
          • Cecolin
          • Hecolin
          • Hanzhou, Zhejiang, China
            Zhejiang Provincial Center for Disease Control and Prevention
          Jun 8, 2022

          COVID-19 Trial in Chengdu (VV116+SOC, SOC)

          Recruiting
          • COVID-19
          • Chengdu, Sichuan, China
            Chengdu Zenitar Biomedical Technology Co., Ltd
          Feb 3, 2023

          Herpes Labialis Trial in Germany (drug, behavioral, procedure)

          Active, not recruiting
          • Herpes Labialis
          • HDIT101 (blinded therapy)
          • +5 more
          • Berlin, Germany
          • +4 more
          Jan 26, 2023

          HCV Care and Treatment for HIV-HCV Co-infected Decentralised

          Not yet recruiting
          • HIV Infection
          • Hepatitis C Infection
          • Blood samples
          • Vinh, Nghe An, Vietnam
          • +1 more
          Aug 16, 2022

          SARS-CoV-2 Infection Trial in Malaysia, Philippines (Azvudine, Placebo)

          Recruiting
          • SARS-CoV-2 Infection
          • Kuala Lumpur, Malaysia
          • +9 more
          Jan 5, 2023

          Helicobacter Pylori Infection Trial in Jinan (14-day high-dose Tegoprazan Dual Therapy (HDDT))

          Not yet recruiting
          • Helicobacter Pylori Infection
          • 14-day high-dose Tegoprazan Dual Therapy (HDDT)
          • Jinan, Shandong, China
            Qilu hosipital
          Jun 28, 2022

          COVID-19, SARS-CoV-2 Infection Trial in Philippines, Thailand (rSIFN-co Nasal Spray, Placebo Nasal Spray)

          Recruiting
          • COVID-19
          • SARS-CoV-2 Infection
          • rSIFN-co Nasal Spray
          • Placebo Nasal Spray
          • San Fernando, Central Luzon, Philippines
          • +3 more
          Aug 15, 2022

          Sternal Wound Infection Trial in Tainan (Vancomycin Hydrochloride, Normal Saline)

          Recruiting
          • Sternal Wound Infection
          • Vancomycin Hydrochloride
          • Normal Saline
          • Tainan, 台南市, Taiwan
            National Cheng Kung University Hospital
          Sep 26, 2022

          Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

          Recruiting
          • Chronic Hepatitis C
          • Chronic Hepatitis B
          • Tenofovir Alafenamide 25 MG
          • Sofosbuvir / Velpatasvir
          • Beijing, Beijing, China
            Peking University First Hospital
          Aug 2, 2021